about
Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approachCurrent advances in biomarkers for targeted therapy in triple-negative breast cancerDiscovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancerEarly diagnostic protein biomarkers for breast cancer: how far have we come?SELDI-TOF serum proteomics and colorectal cancer: a current overview.Breast cancer proteomics: a review for clinicians.A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissueIdentification of serum protein markers for breast cancer relapse with SELDI-TOF MS.Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.Comparison of functional proteomic analyses of human breast cancer cell lines T47D and MCF7Mass-spectrometry-based clinical proteomics--a review and prospective.Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS.Proteomic studies in breast cancer (Review).Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approachThe consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle.Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry technology for the diagnosis of colorectal adenoma.Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased.Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS.Rapid peptidomic profiling of peritoneal fluid by MALDI-TOF mass spectrometry for the identification of biomarkers of endometriosis.Enhancing MALDI time-of-flight mass spectrometer performance through spectrum averagingIdentification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging.Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.Endobiogeny: a global approach to systems biology (part 1 of 2).Photonic crystal enhanced fluorescence for early breast cancer biomarker detection.Optimal management of bone metastases in breast cancer patients.Implications of functional proteomics in breast cancer.Fluopsin C induces oncosis of human breast adenocarcinoma cells.Triple-negative breast cancer: present challenges and new perspectives.Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.Proteomic approaches in myeloid leukemia.iTRAQ-based proteomics monitors the withering dynamics in postharvest leaves of tea plant (Camellia sinensis).Metabolomics fingerprinting of the human seminal plasma of asthenozoospermic patients
P2860
Q24337286-C7667947-6320-499F-A07C-C868FF05111CQ28074202-24FAE011-249C-424F-B205-05FFE0808CBFQ28743801-58493138-1FC5-474D-B52D-464FA38ADFB7Q31043570-0556F515-89F5-41EC-8F39-D7DE91D8C1BEQ33628047-1FB4C247-5088-4777-85B0-99A11A0E415CQ33862872-8205D738-8E5B-4785-A8D2-FE7D52A4638AQ33889245-BA759165-0D16-4BE5-8DB1-6FE329A9290FQ33891208-63544E13-1264-4B7B-AAB9-18416620C054Q34086346-AF5F7FDF-2E49-4FC9-8993-328B36AD36B8Q34181752-CCDD6A21-A548-4459-9680-5A87D1769CD4Q34252113-804A0923-F68F-4BA7-A366-587A74C5DA2EQ34302950-5D8F5035-F36C-4F6D-AFD3-924E46EF0E61Q34319634-CDD7BA37-A2FB-47B4-B8DA-9DB0A61E7146Q34477298-09EA51BB-8B71-4996-8831-6F1B3548B852Q34725150-7D561C14-44D5-4565-90C4-AE9685EB69F0Q34801966-B358C2FE-90C1-4AC0-BBEC-BD3FC4FE32A6Q35093772-4DBDB7C6-5A1B-49E3-B656-F9710C03CE69Q35169678-E217E226-0C92-4E5C-A710-4E8D8A5B966AQ35222891-946BB15D-EB9F-402E-91BD-4FFDB68A5848Q35583636-573F83B7-963F-4613-A3FE-ABE0D30127BFQ35777081-7FA2862B-6C96-4FEA-BC78-72D25BC5152CQ36216932-CBC8C592-F001-4CF4-A407-FE6F8346673CQ37324095-B7C3ABC7-0D29-4739-832F-A855E0CC772FQ37350996-5C7B46D9-0FBA-4133-8748-902985ECEE89Q37355487-C7F7511E-695E-4276-B637-6027BE04665AQ37698227-C962EAC9-A997-40F7-BA12-075DA8C1B96BQ37729319-3831F72A-BEE2-4745-9F12-279DEADE229AQ37764168-310220CA-4A03-445C-8D7F-F220C12EFAF2Q37805245-06DD6C56-F7E7-48FA-8DA5-01F782250D50Q37831255-9F79D034-A0B1-4CDC-AA4F-DA0EB6F6CDEAQ38635775-6EE8FA92-8B62-4C70-A830-BA8401EE4196Q57165173-A12668C7-29BC-439F-9C97-A7E5DF2B3438
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Clinical proteomics in breast cancer: a review.
@ast
Clinical proteomics in breast cancer: a review.
@en
type
label
Clinical proteomics in breast cancer: a review.
@ast
Clinical proteomics in breast cancer: a review.
@en
prefLabel
Clinical proteomics in breast cancer: a review.
@ast
Clinical proteomics in breast cancer: a review.
@en
P2093
P2860
P1476
Clinical proteomics in breast cancer: a review.
@en
P2093
Jan H M Schellens
Jos H Beijnen
Marie-Christine W Gast
P2860
P2888
P356
10.1007/S10549-008-0263-3
P407
P577
2008-12-11T00:00:00Z
P5875
P6179
1014870482